Article examines studies on antidepressants, autism spectrum disorders

A new article published by JAMA Pediatrics reviews and analyzes a small collection of studies on fetal exposure to antidepressants and autism spectrum disorders (ASDs).

Florence Gressier, M.D., Ph.D., of the Bicêtre University Hospital, Le Kremlin-Bicêtre, France, and coauthors identified 10 relevant studies with inconsistent results to examine ASDs and to antidepressants during pregnancy for each trimester and during the preconception period.

"Future studies, comprising an assessment of diagnoses, severity of illness and treatments at different stages in pregnancy and substance abuse, are needed and could help disentangle the role of the mother's psychiatric condition and psychotropic drug use in the risk for ASDs.

Further detailed to address these confounding factors are required to investigate the association between antidepressant exposure and ASDs," the article concludes.

Explore further

No association between mother flu in pregnancy and increased child autism risk

More information: JAMA Pediatr. Published online April 17, 2017. DOI: 10.1001/jamapediatrics.2017.0124
Journal information: JAMA Pediatrics

Citation: Article examines studies on antidepressants, autism spectrum disorders (2017, April 17) retrieved 12 May 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments